A detailed history of Casdin Capital, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 71,254,677 shares of LAB stock, worth $130 Million. This represents 10.68% of its overall portfolio holdings.

Number of Shares
71,254,677
Previous 63,959,677 11.41%
Holding current value
$130 Million
Previous $113 Million 21.48%
% of portfolio
10.68%
Previous 9.76%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.42 - $2.35 $10.4 Million - $17.1 Million
7,295,000 Added 11.41%
71,254,677 $138 Million
Q2 2024

Aug 14, 2024

BUY
$1.65 - $2.92 $3.39 Million - $5.99 Million
2,052,072 Added 3.31%
63,959,677 $113 Million
Q1 2024

May 15, 2024

BUY
$1.87 - $2.78 $114 Million - $169 Million
60,707,605 Added 5058.97%
61,907,605 $168 Million
Q2 2023

Aug 14, 2023

BUY
$1.47 - $2.56 $1.76 Million - $3.07 Million
1,200,000 New
1,200,000 $2.32 Million

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.